<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04760301</url>
  </required_header>
  <id_info>
    <org_study_id>0354-19-MMC</org_study_id>
    <nct_id>NCT04760301</nct_id>
  </id_info>
  <brief_title>Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss</brief_title>
  <official_title>Local Tranexamic Acid During Vaginal Hysterectomy to Reduce Blood Loss</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal&#xD;
      hysterectomy to reduce blood loss during operation&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized control trial will investigate whether local tranexamic acid is efficient for&#xD;
      decreasing bleeding during vaginal hysterectomy.&#xD;
&#xD;
      The investigators will randomize local placebo (saline) vs. local 1 gr tranexamic acid; IV&#xD;
      1gr diluted in 100 ml saline and IV 100 ml saline at the beginning of surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 16, 2021</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood loss during operation - measure in ml</measure>
    <time_frame>End of surgery</time_frame>
    <description>At the end of the surgery, surgeon will measure the blood in the suction can</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Blood Loss</condition>
  <arm_group>
    <arm_group_label>local tranexamic acid injection to cervix</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 gr of Tranexamic acid diluted in 10 ml saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>local normal saline injection to cervix</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20 ml of saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV 1 g tranexamic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 gr of Tranexamic acid diluted in 100 ml saline- IV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV 1 g normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>100 ml saline- IV</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>local tranexamic acid injection</intervention_name>
    <description>local tranexamic acid injection to cervix- 1 g tranexamic acid diluted in 10 ml saline</description>
    <arm_group_label>local tranexamic acid injection to cervix</arm_group_label>
    <other_name>Hexakapron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>local normal saline injection to cervix</intervention_name>
    <description>local normal saline injection to the cervix- 20 ml saline</description>
    <arm_group_label>local normal saline injection to cervix</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV 1 g tranexamic acid</intervention_name>
    <description>IV 1 g tranexamic acid diluted in 100 ml saline</description>
    <arm_group_label>IV 1 g tranexamic acid</arm_group_label>
    <other_name>Hexakapron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IV 1 g normal saline</intervention_name>
    <description>IV 100 ml normal saline</description>
    <arm_group_label>IV 1 g normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  20-90 years old female patients going through vaginal hysterctomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  massive bleeding during operation due to major vessles injury&#xD;
&#xD;
          -  known coagulopathies&#xD;
&#xD;
          -  sensitivity to tranexamic acid&#xD;
&#xD;
          -  medical need in tranexamic acid administration during operation due to bleeding&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yair Daykan, M.D</last_name>
    <phone>0542198231</phone>
    <email>yair.dykan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gal Cohen, M.D</last_name>
    <phone>0545915788</phone>
    <email>galcwork@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar Saba,</city>
        <zip>11125</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yair M Daykan, MD</last_name>
      <phone>972-54-2198231</phone>
      <email>yair.dykan@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Meir medical center</name>
      <address>
        <city>Kfar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yair Dykan, MD</last_name>
      <phone>09-7472209</phone>
      <email>yair.dykan@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 16, 2021</study_first_submitted>
  <study_first_submitted_qc>February 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>February 18, 2021</last_update_submitted>
  <last_update_submitted_qc>February 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meir Medical Center</investigator_affiliation>
    <investigator_full_name>Yair Daykan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

